Peijia Medical chairman boosts stake, signals confidence

Dr. Yi Zhang, executive director, CEO, and chairman of Peijia Medical Limited, has initiated a shareholding increase in the company. Through his controlled corporation, Dr. Zhang began purchasing shares on the open market starting December 1, 2025. The total aggregate consideration for these purchases is not expected to exceed HK$15,000,000.

This move, according to Dr. Zhang, underscores his affirmation of Peijia Medical's intrinsic value and his strong confidence in its development prospects and growth potential. He has also indicated that further increases in his shareholdings may occur as deemed appropriate and in compliance with regulations.

Following this increase, Peijia Medical continues to maintain a sufficient public float, meeting the requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.